Gaps in the achievement of effectiveness of HCV treatment in national VA practice
Open Access
- 13 July 2011
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 56 (2) , 320-325
- https://doi.org/10.1016/j.jhep.2011.05.032
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Efficacy, effectiveness, and comparative effectiveness in liver disease†Hepatology, 2010
- Effectiveness of pegylated interferon/ribavirin combination in ‘real world’ patients with chronic hepatitis C virus infectionAlimentary Pharmacology & Therapeutics, 2008
- The effect of early virological response in health‐related quality of life in HCV‐infected patientsJournal of Medical Virology, 2008
- Health-related quality of life in patients with chronic hepatitis C and advanced fibrosisJournal of Hepatology, 2007
- Antiviral Therapy for Cirrhotic Hepatitis C: Association with Reduced Hepatocellular Carcinoma Development and Improved SurvivalAnnals of Internal Medicine, 2005
- Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis CAnnals of Internal Medicine, 2004
- Effectiveness of interferon alfa‐2b/ribavirin combination therapy for chronic hepatitis C in a clinic settingThe Medical Journal of Australia, 2003
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus InfectionNew England Journal of Medicine, 2002
- Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis CGastroenterology, 2002
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialPublished by Elsevier ,2001